Genetics of Hearing Loss in Middle Eastern Families

中东家庭听力损失的遗传学

基本信息

  • 批准号:
    7627319
  • 负责人:
  • 金额:
    $ 50.09万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-04-07 至 2011-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The goal of this project is to find and characterize genes responsible for hereditary hearing impairment (HHI) in highly informative Middle Eastern kindreds. Genes identified in these consanguineous families are important to the non-consanguineous U.S. deaf population because all genes for HHI illuminate universal features of hearing biology and because such genes often harbor other mutations leading to recessive or dominant HHI in populations worldwide. We have thus far identified DFNA15 as POU4F3, DFNB30 as MYO3A, and now DFNB28 as a novel isoform of TARA, which we name OTOTARA. We are developing a mouse model of the MYO3A/DFNB30 nonsense mutation. In two other kindreds, we mapped genes for hearing loss to small intervals on chromosomes 2q31 and 11q14.3-q21. These regions do not harbor known deafness genes, so these kindreds will reveal two more novel genes for HHI. In four other families, we identified new alleles of known deafness genes, suggesting that genetic hearing loss in this population is similar to that elsewhere. In the 156 families with HHI enrolled in our project, GJB2 (connexin 26) is responsible for HHI in only 17 (11%) of families, reflecting the high frequency of HHI due to other genes. In the next cycle of this project, our collaboration proposes: (1) to further characterize wildtype and mutant OTOTARA (2) to identify genes for recessive, nonsyndromic HHI on chromosomes 2q31 and 11q14.3-q21 (3) to undertake positional identification of genes for HHI in four additional kindreds (4) to complete the MYO3A/DFNB30 knock-in mouse and characterize its phenotype The strengths of this collaboration are the enthusiastic participation in the project of extended informative kindreds with HHI, the large number of these kindreds likely to carry mutations in heretofore unknown hearing-related genes, and our demonstrated success in mapping, identifying, and characterizing genes for HHI in these families.
描述(由申请人提供):该项目的目标是在信息丰富的中东人种中发现和表征与遗传性听力障碍(HHI)有关的基因。在这些近亲家庭中发现的基因对非近亲美国聋人群体很重要,因为所有的HHI基因都阐明了听力生物学的普遍特征,因为这些基因通常包含其他突变,导致世界范围内人群的隐性或显性HHI。到目前为止,我们已经确定DFNA15为POU4F3, DFNB30为MYO3A,现在DFNB28是TARA的一种新的异构体,我们将其命名为OTOTARA。我们正在开发MYO3A/DFNB30无义突变的小鼠模型。在另外两种类型中,我们将听力损失的基因定位到染色体2q31和11q14.3-q21上的小间隔。这些区域没有已知的耳聋基因,因此这些类型将揭示两个新的HHI基因。在另外四个家庭中,我们发现了已知耳聋基因的新等位基因,这表明该人群的遗传性听力损失与其他地方相似。在我们项目纳入的156个HHI家族中,GJB2 (connexin 26)仅在17个(11%)家族中负责HHI,反映了其他基因导致HHI的高频率。在这个项目的下一个周期中,我们的合作提议:

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARY-CLAIRE KING其他文献

MARY-CLAIRE KING的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARY-CLAIRE KING', 18)}}的其他基金

1/3 Genomics of Schizophrenia in the South African Xhosa
1/3 南非科萨人精神分裂症的基因组学
  • 批准号:
    10322744
  • 财政年份:
    2021
  • 资助金额:
    $ 50.09万
  • 项目类别:
Whole Genome Sequencing and Transcriptome Analysis in Schizophrenia Cases and Controls from the Xhosa Population
科萨族精神分裂症病例和对照的全基因组测序和转录组分析
  • 批准号:
    9250897
  • 财政年份:
    2016
  • 资助金额:
    $ 50.09万
  • 项目类别:
GENOMIC ANALYSIS OF INHERITED BREAST AND OVARIAN CANCER
遗传性乳腺癌和卵巢癌的基因组分析
  • 批准号:
    9123570
  • 财政年份:
    2015
  • 资助金额:
    $ 50.09万
  • 项目类别:
GENOMIC ANALYSIS OF INHERITED BREAST AND OVARIAN CANCER
遗传性乳腺癌和卵巢癌的基因组分析
  • 批准号:
    10222586
  • 财政年份:
    2015
  • 资助金额:
    $ 50.09万
  • 项目类别:
GENOMIC ANALYSIS OF INHERITED BREAST AND OVARIAN CANCER
遗传性乳腺癌和卵巢癌的基因组分析
  • 批准号:
    9751788
  • 财政年份:
    2015
  • 资助金额:
    $ 50.09万
  • 项目类别:
COMPLETE VARIANT PROFILING OF ALL KNOWN BREAST CANCER GENES
所有已知乳腺癌基因的完整变异分析
  • 批准号:
    8630707
  • 财政年份:
    2013
  • 资助金额:
    $ 50.09万
  • 项目类别:
COMPLETE VARIANT PROFILING OF ALL KNOWN BREAST CANCER GENES
所有已知乳腺癌基因的完整变异分析
  • 批准号:
    9330794
  • 财政年份:
    2013
  • 资助金额:
    $ 50.09万
  • 项目类别:
2/3-GENOMICS OF SCHIZOPHRENIA IN THE SOUTH AFRICAN XHOSA
2/3-南非科萨人精神分裂症的基因组学
  • 批准号:
    8436081
  • 财政年份:
    2013
  • 资助金额:
    $ 50.09万
  • 项目类别:
2/3 Genomics of Schizophrenia in the South African Xhosa
2/3 南非科萨人精神分裂症的基因组学
  • 批准号:
    9075382
  • 财政年份:
    2013
  • 资助金额:
    $ 50.09万
  • 项目类别:
2/3-GENOMICS OF SCHIZOPHRENIA IN THE SOUTH AFRICAN XHOSA
2/3-南非科萨人精神分裂症的基因组学
  • 批准号:
    8987596
  • 财政年份:
    2013
  • 资助金额:
    $ 50.09万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 50.09万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 50.09万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 50.09万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 50.09万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 50.09万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 50.09万
  • 项目类别:
    Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 50.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 50.09万
  • 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 50.09万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 50.09万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了